HIF1A and melanoma: Since our previous studies reported that HIF-1α is a molecular target for SIM cytotoxicity in B16.F10 murine melanoma cells [23, 24] we investigated whether the lipophilic statin could improve the antitumor efficacy of an anti-angiogenic agent, DMXAA, when these drugs were co-administered.